• 1
    Leifer CE, Matus RE. Chronic lymphocytic leukemia in the dog: 22 cases (1974–1984). J Am Vet Med Assoc 1986;189:214217.
  • 2
    Vernau W, Moore PF. An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction. Vet Immunol Immunopathol 1999;69:145164.
  • 3
    Tasca S, Carli E, Caldin M, et al. LS Hematologic abnormalities and flow cytometric immunophenotyping results in dogs with hematopoietic neoplasia: 210 cases (2002–2006). Vet Clin Pathol 2009;38:212.
  • 4
    Adam F, Villiers E, Watson S, et al. Clinical pathological and epidemiological assessment of morphologically and immunologically confirmed canine leukaemia. Vet Comp Oncol 2009;7:181195.
  • 5
    Harvey JW, Terrell TG, Hyde DM, et al. Well-differentiated lymphocytic leukemia in a dog: Long-term survival without therapy. Vet Pathol 1981;18:3747.
  • 6
    Fujino Y, Sawamura S, Kurakawa N, et al. Treatment of chronic lymphocytic leukaemia in three dogs with melphalan and prednisolone. J Small Anim Pract 2004;45:298303.
  • 7
    Rai KR, Sawitsky A. A review of the prognostic role of cytogenetic, phenotypic, morphologic, and immune function characteristics in chronic lymphocytic leukemia. Blood Cells 1987;12:327338.
  • 8
    Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981;48:198206.
  • 9
    Breen M, Modiano JF. Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans—man and his best friend share more than companionship. Chromosome Res 2008;16:145154.
  • 10
    Hoyer JD, Ross CW, Li CY, et al. True T-cell chronic lymphocytic leukemia: A morphologic and immunophenotypic study of 25 cases. Blood 1995;86:11631169.
  • 11
    Workman HC, Vernau W. Chronic lymphocytic leukemia in dogs and cats: The veterinary perspective. Vet Clin North Am Small Anim Pract 2003;33:13791399.
  • 12
    Williams MJ, Avery AC, Lana SE, et al. Canine lymphoproliferative disease characterized by lymphocytosis: Immunophenotypic markers of prognosis. J Vet Intern Med 2008;22:596601.
  • 13
    Botsch V, Küchenhoff H, Hartmann K, et al. Retrospective study of 871 dogs with thrombocytopenia. Vet Rec 2009;164:647651.
  • 14
    Comazzi S, Gelain ME, Spagnolo V, et al. Flow cytometric patterns in blood from dogs with non-neoplastic and neoplastic hematologic diseases using double labeling for CD18 and CD45. Vet Clin Pathol 2006;35:4754.
  • 15
    Fournel-Fleury C, Magnol JP, Bricaire P, et al. Cytohistological and immunological classification of canine malignant lymphomas: Comparison with human non-Hodgkin's lymphomas. J Comp Pathol 1997;117:3559.
  • 16
    Ponce F, Marchal JP, Turinelli V, et al. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology. Vet Pathol 2010;47:414433.
  • 17
    Jacobs RM, Messick JB, Valli VE. Tumors of the hemolymphatic system. In: MeutenDJ., ed. Tumors in Domestic Animals, 4th ed. Ames, IA: Iowa State Press; 2002:177180.
  • 18
    Vail DM, Young KM. Haematopoietic tumors. In: WithrowSJ, VailDM, eds. Withrow and Mac Ewen's Small Animal Clinical Oncology. St Louis, MO: Saunders; 2007:722725.
  • 19
    Vallespí T, Montserrat E, Sanz MA. Chronic lymphocytic leukaemia: Prognostic value of lymphocyte morphological subtypes. A multivariate survival analysis in 146 patients. Br J Haematol 1991;77:478485.
  • 20
    Helfand SC, Modiano JF. Chronic lymphocytic leukemia. In: FeldmanBF, ZinklJG, JainNC, eds. Schalm's Veterinary Hematology, 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2000:638641.
  • 21
    Tsimberidou AM, Keating MJ. Richter syndrome: Biology, incidence, and therapeutic strategies. Cancer 2005;103:216228.
  • 22
    Rossi D, Gaidano G. Richter syndrome: Molecular insights and clinical perspectives. Hematol Oncol 2009;27:110.
  • 23
    Vroblová V, Smolej L, Vrbacký F, et al. Biological prognostic markers in chronic lymphocytic leukemia. Acta Medica (Hradec Kralove) 2009;52:38.
  • 24
    Rossi D, Lobetti Bodoni C, Genuardi E, et al. Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia. Leukemia 2009;23:10621072.